Company / Income Tax
IOVANCE BIOTHERAPEUTICS, INC. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$2.1M
FY2025
5-year range
-$3.5M / $0
FY2021-FY2025
Trend
+26.8%
vs FY2024
Sector context
#184 of 204
Health Care
What the data says
Among 204 Health Care companies, IOVANCE BIOTHERAPEUTICS, INC. is in the top 10% for income tax. Increased from -$3M to -$2M over the past 2 years.
Based on SEC 10-K filings.
-$2M in FY2025.
Increased from -$3M to -$2M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 204This company -$2.1M Sector average $118.7M
▼
-101.7% below sector average
Key checks
Key Insights
- In FY2025, income tax increased 26.8% year-over-year.
- Ranks #184 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2022.
- Lowest income tax in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.1M | +26.8% |
| FY2024 | -$2.8M | +18.7% |
| FY2023 | -$3.5M | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026